Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adult Vaccines Stand To Gain From Preventive Care Rule, Outreach Is Next

Executive Summary

New government requirements regarding commercial insurance coverage for preventive care mark an important step to broadening access for adult vaccines. Mandated by the health reform law, the requirements are part of an interim final rule from HHS, the Labor Department and the Treasury Department, scheduled to appear in the Federal Register July 19

You may also be interested in...



Cost-Effectiveness Colors ACIP Decision On Hep B Vaccination For Diabetics

The Centers for Disease Control’s Advisory Committee on Immunization Practices limited its Oct. 25 recommendation for vaccinating adult diabetics against hepatitis B to those under 60 years of age because of cost effectiveness considerations.

Cost-Effectiveness Colors ACIP Decision On Hep B Vaccination For Diabetics

The Centers for Disease Control’s Advisory Committee on Immunization Practices limited its Oct. 25 recommendation for vaccinating adult diabetics against hepatitis B to those under 60 years of age because of cost effectiveness considerations.

Flu Vaccines To Get A Boost From Medicaid Quality Measures

An HHS Agency for Healthcare Research and Quality National Advisory Council subcommittee has agreed that administering flu shots for adults ages 50 to 64 should be included in quality measures for state Medicaid programs being developed under provisions of the Affordable Care Act.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS052422

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel